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Recent progress in sequencing the genomes of several Leishmania species, causative agents of cutaneous, mucocutaneous and visceral
leishmaniasis, is revealing unusual features of potential relevance to parasite virulence and pathogenesis in the host. While the genomes of
Leishmania major, Leishmania braziliensis and Leishmania infantum are highly similar in content and organisation, species-speciﬁc genes
and mechanisms distinguish one from another. In particular, the presence of retrotransposons and the components of a putative RNA
interference machinery in L. braziliensis suggest the potential for both greater diversity and more tractable experimentation in this Leish-
mania Viannia species.
 2007 Australian Society for Parasitology Inc. Published by Elsevier Ltd.
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Species of the genus Leishmania cause a diverse spec-
trum of infectious diseases, the leishmaniases, in tropical
and subtropical regions of the world (reviewed in Murray
et al., 2005). Belonging to the order Kinetoplastida and
the family Trypanosomatidae, mammalian-infective spe-
cies of the genus can be divided into two subgenera, Leish-
mania (Leishmania) and Leishmania (Viannia), which
diﬀer principally in the site of parasite development within
the female sandﬂy vector (reviewed in Sacks and Kamhawi,
2001). Once ﬂagellated metacyclic promastigote stages are
transmitted from vector to mammalian host, parasites
enter resident tissue macrophages and transform into aﬂa-
gellated replicative amastigotes, often inducing immuno-
inﬂammatory responses and persistent tissue infection.
The fate of these intracellular parasites determines disease0020-7519  2007 Australian Society for Parasitology Inc. Published by Elsev
doi:10.1016/j.ijpara.2007.05.015
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E-mail address: dfs501@york.ac.uk (D.F. Smith).type, which can range from cutaneous or mucocutaneous
infection to diﬀuse cutaneous or visceral disease. The prin-
cipal factors contributing to disease outcome are the infect-
ing parasite species and immunological status of the host,
including a well-established role for host genetic variation
(reviewed in Lipoldova and Demant, 2006). Attributing
the relative importance of these factors to disease outcome
in humans is a complex area, however, particularly given
the overlap in pathology associated with infection with dif-
ferent Leishmania species (Guerbouj et al., 2001;McMa-
hon-Pratt and Alexander, 2004; Wilson et al., 2005;
BenSaid et al., 2006). While multiple species cause cutane-
ous disease (see Table 1) and only three are usually consid-
ered as visceralising types (Leishmania donovani,
Leishmania infantum and Leishmania chagasi), cutaneous
lesions attributed to these latter species have also been
reported (Gramiccia et al., 1995; Noyes et al., 1997; Gumy
et al., 2004; BenSaid et al., 2006), while isolated cases of
visceral disease due to cutaneous species have been
recorded as well (Barral et al., 1991). Variable disease
phenotype has also been observed in naturally andier Ltd. Open access under CC BY license.
Table 1
Human-infective species of the Leishmania genus
Old World species New World species Disease type
L. major complex L. mexicana complex Cutaneous
L. (L.) major L. (L.) mexicana
L. (L.) tropica L. (L.) amazonensis
L. (L.) aethiopica L. (L.) pifanoi
L. (L.) venezuelensis
L. (Viannia) subgenus
L. (V.) braziliensis
L. (V.) panamensis
L. (V.) guyanensis
L. (V.) peruviana
L. (V.) lansoni
L. (V.) braziliensis Mucocutaneous
L. (L.) aethiopica L. (L.) amazonensis Diﬀuse cutaneous
L. (L.) pifanoi
L. donovani complex Visceral
L. (L.) donovani
L. (L.) infantum* L. (L.) chagasi*
The main species complexes and subgenus are shown in bold; the species
with complete genome sequences either available or being generated are
underlined.
* Species that can also be associated with cutaneous leishmaniasis.
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importance of all contributing factors to clinical disease
is a challenging objective.
A number of parasite factors aﬀecting pathogenesis in
the host have already been well-characterised. These
include the surface zinc metalloprotease GP63 (or leish-
manolysin) which protects promastigotes against host lysis
by cleavage of complement, enhances phagocytosis and has
recently been shown to protect against antimicrobial pep-
tide-induced apoptotic killing (reviewed in Yao et al.,
2005; Kulkarni et al., 2006); several parasite-derived cys-
teine proteases which can function as virulence factors
(Mottram et al., 2004) and the complex glycoconjugates,
lipophosphoglycan and the proteophosphoglycans, which
promote parasite survival in the vector and host by a range
of mechanisms (reviewed by Beverley and Turco, 1998; Ilg,
2000; Sacks and Kamhawi, 2001; Turco et al., 2001; Desco-
teaux and Turco, 2002; Lodge and Descoteaux, 2005).
Sequencing the genomes of representative parasite spe-
cies provides a global framework within which to investi-
gate the contribution of these and other parasite factors
to the diverse forms of leishmaniasis and address the ques-
tion: what is the contribution of parasite genotype to dis-
ease phenotype?2. Sequencing the Leishmania genomes: which species?
The decision to initiate sequencing programmes for
three kinetoplastid organisms, Leishmania, Trypanosoma
brucei and Trypanosoma cruzi (the Tritryp genome pro-
jects), was made in principal at a Oswaldo Cruz Founda-
tion (FIOCRUZ) – World Health Organization Special
Programme for Research and Training in Tropical Dis-eases (WHO/TDR) Parasite Genome Network Planning
Meeting in Rio de Janeiro in 1994. Although the available
technology for completion of such large genomes was lack-
ing at that time, these projects were considered feasible
given the organisation of a committed consortium of par-
ticipating laboratories, suﬃcient funding and anticipated
advances in sequencing technology. Thirteen years later,
three completed Leishmania genomes (Leishmania major,
L. infantum, Leishmania braziliensis) are in the public
domain (Ivens et al., 2005; Peacock et al., 2007), with
sequencing of a fourth (Leishmania mexicana) in progress
(http://www.genedb.org/). These ﬁrst four species were
chosen to represent the main species complexes of the L.
Leishmania subgenus together with the best-characterised
species of the L. Viannia subgenus. The strains selected
were all infective, allowing study of host responses in suit-
able rodent models in vivo, and adapted for maintenance
and manipulation in the laboratory (Laurentino et al.,
2004; Ivens et al., 2005; Denise et al., 2006). Importantly,
the three completed genomes represent species that usually
give rise to distinct disease types (Table 1).
Leishmania major was the ﬁrst species to be sequenced
and has provided the model for subsequent genomic anal-
yses. L. major is a causative agent of cutaneous leishmani-
asis (CL), the most common disease form that is usually
self-healing in humans but leaves unsightly scars in those
aﬀected (Table 1). Widespread in Africa and Asia, CL
caused by L. major is predominantly a zoonotic infection,
with parasites maintained in rodent reservoir hosts follow-
ing transmission by phlebotomine sandﬂies. In the labora-
tory, L. major has been one of the principal experimental
species used to dissect the roles of TH1/TH2 cells in
response to infection in susceptible and resistant hosts
(reviewed in Sacks and Noben-Trauth, 2002).
The case for sequencing a visceralising species of Leish-
mania as the second genome to be analysed was over-
whelming: visceral leishmaniasis (VL) is the most serious
disease form and frequently fatal if left untreated. Closely
related species of the L. donovani complex are found in dif-
ferent geographical regions: L. donovani is the primary
cause of VL in the Indian subcontinent and East Africa,
L. infantum in the Mediterranean region and L. chagasi
in the New World (Table 1). Humans are the only known
reservoir of L. donovani while canines, especially domestic
and stray dogs, provide the reservoir hosts for L. infantum
and L. chagasi. While the last two species are generally con-
sidered to be genetically identical (Mauricio et al., 2000), all
three species are very similar as demonstrated in recent
comprehensive phylogenetic studies using both non-coding
and protein-coding sequences (Kuhls et al., 2005, 2007;
Mauricio et al., 2006; Lukes et al., 2007). The choice of a
prevalent L. infantum strain for genome sequencing was
made on the basis of its virulence in animals, transmissibil-
ity in sandﬂies and adaptability to laboratory experimenta-
tion (Denise et al., 2006).
The New World species L. braziliensis, within the subge-
nus L. (Viannia), is the third and most divergent species
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mucocutaneous leishmaniasis (MCL) in tropical America.
Originally associated with close contact with the forest
environment, it is now accepted that L. braziliensis trans-
mission may occur in peri-domestic and domestic habitats.
More recently, studies on the reservoir hosts strongly sug-
gest that a number of rodent species are involved, including
domestic rats (Grimaldi and Tesh, 1993; Brandao-Filho
et al., 1994; Oliveira et al., 2005).
The most severe pathology associated with this species is
the disease aﬀecting mucous membranes, mainly the ante-
rior nasal region and occasionally the pharynx and larynx,
which can result in destruction of the cartilagenous tissue.
Most frequently, mucosal disease occurs after the appear-
ance of cutaneous lesions and its diagnosis may happen
months or years after treatment of the primary lesion (Zajt-
chuk et al., 1989). However, recent clinical investigation
indicates that mucosal infection may be present, but not
diagnosed, concomitantly with the primary cutaneous
lesion (Boaventura et al., 2006). This is a relevant issue
because the patient usually does not recognise MCL until
partial destruction of the nose mucosa and/or cartilage
occurs. Treatment of such cases is often diﬃcult and death
may occur as a result of uncontrollable secondary
infections.
3. The L. major genome
The L. major genome is composed of both nuclear and
independently replicating mitochondrial or kinetoplast
DNA. The structure and function of kinetoplastid DNA
have been reviewed recently (Lukes et al., 2005) and will
not be discussed further here.
Prior to publication of the Tritryp kinetoplastid gen-
omes in 2005, relatively little was known about the overall
physical architecture of kinetoplastid chromosomes. How-
ever, earlier studies on antigenic variation in T. brucei had
deﬁned telomeric expression sites for variant surface glyco-Fig. 1. The structure of a typical Leishmania chromosome: chromosome 2 of L
genes are shown as coloured boxes, coded according to the categories ind
distribution of the Leishmania-speciﬁc and scb-galactosyltransferase (SCG) re
chromosomal features include the telomeric hexamer repeats, the spliced leader
transposons.protein (VSG) as polycistronic transcription units
(reviewed in Pays et al., 1994), while work on RNA
processing mechanisms in T. brucei and Leishmania had
demonstrated linkage between 3 0-polyadenylation sites
and 5 0-trans-splicing of adjacent genes, suggesting a cou-
pled mechanism that could be processive along a chromo-
some (LeBowitz et al., 1993; Ullu et al., 1993; Matthews
et al., 1994). The ﬁrst whole chromosome sequence of L.
major (Myler et al., 1999) revealed an unusual pattern of
gene distribution, consistent with the polycistronic tran-
scription model. Of the 79 identiﬁed genes, 29 were present
as a contiguous unit on one DNA strand with the remain-
ing 50 as a second unit on the opposite strand. Further
chromosome sequencing revealed that the genes on other
L. major chromosomes are similarly aligned in long arrays
that appear to be transcribed as a single unit (Martinez-
Calvillo et al., 2003; see Fig. 1) prior to trans-splicing and
polyadenylation. These directional gene clusters (DGCs)
range in size from a few to hundreds of genes stretching
over 1 Mb of DNA. DGCs are separated by AT-rich
strand switch regions (SSRs) believed to contain sites for
transcription initiation and termination (Martinez-Calvillo
et al., 2004). Whole genome microarray experiments have
recently conﬁrmed that most genes are constitutively tran-
scribed in Leishmania (Holzer et al., 2006; Leifso et al.,
2007). Diﬀerential gene expression between diﬀerent life
cycle stages is subsequently mediated by downstream pro-
cessing events aﬀecting mRNA stability and translation
(Boucher et al., 2002; Myung et al., 2002).
The DGC type of chromosomal organization is remark-
ably well-conserved in all the kinetoplastids sequenced to
date, with most of the L. major chromosomes being com-
pletely syntenic with corresponding regions in the larger
T. brucei chromosomes (El-Sayed et al., 2005a), despite
separation of these two species by at least 200 million years
of evolution (Stevens et al., 2001). DGCs do not contain
clusters of genes of related function similar to the organisa-
tion of prokaryotic operons, however.eishmania major. The location and coding strands of the 74 protein-coding
icated below. The majority are genes conserved with other eukaryotes;
peat family genes are also shown, together with three pseudogenes. Other
tandem array and the ribosomal mobile element (RIME) degenerate LTR
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shared by L. major and the other Tritryps, organization of
the L. major chromosome ends is distinctive, with short
and highly conserved subtelomeric regions bordering dis-
tinctive repeat sequences that precede heterogeneous telo-
meres (Ivens et al., 2005). Interestingly, there are no large
subtelomeric multigene families encoding proteins involved
in host immune evasion – these are features not only of the
T. brucei and T. cruzi genomes but also of other protozoan
pathogen genomes such as those of Plasmodium spp. (Hall
et al., 2002). Associated with this lack of telomeric repeated
genes is a lack of transposable elements in the L. major gen-
ome (Bringaud et al., 2006) – these mobile sequence units
are associated with gene re-arrangements in the subtelo-
meric regions of Trypanosoma spp. (Berriman et al., 2005).
4. The L. major genome – gene content
The 33 Mb genome of L. major is predicted to contain
8,300 genes, a ﬁgure likely to be accurate given the dis-
tinct codon bias in the coding regions and the rarity of
cis-splicing in this species, features that make gene predic-
tion reliable (Ivens et al., 2005; Peacock et al., 2007).
Within this gene complement are a number of tandemly
arrayed gene families, a kinetoplastid feature that may
overcome the limitations of polycistronic transcription by
increasing gene dosage (see below). Properties of the L.
major genome, in comparison with the L. infantum, L. bra-
ziliensis and T. brucei genomes, are listed in Table 2.Table 2
Genome facts: the Leishmanias versus Trypanosoma brucei
Leishmania major Leishmania infan
Total size (Mb) 32.8 32.1
Contigs 36 562
No. of chromosomes 36 36
Chromosome size range
(Mb)
0.3–2.8 0.3–2.8
Overall G + C content % 59.7 59.3
No. of genes 8,298 8,154
No. of pseudogenes 97 41
Average gene size (bp) 1,894 1,868
Gene density (per Mb) 252 235
Coding percentage 48.0 44.0
Coding G + C content % 62.5 62.4
No. of DGCs 133 133
Average DGC length (kb/
genes)
240/61 n/a
No. of tRNAs 83 62
No. of snoRNAs 693 n/a
No. of snRNAs 6 n/a
No. of rRNAs 63 n/a
Average intergenic size 1,939 2,049
Active mobile elements None (degenerate RIME/
DIRE)
None (degenerat
DIRE)
Data included in this Table are correct as of February 2007 (for Leishmania sp
included, not the intermediate or mini-chromosomes. DGC, directional gene
related element; TATE, telomere-associated transposable element; SLACS, S
repetitive element; VIPER, LTR retroelement related to SIRE.The L. major genes can be divided into three broad
categories. Around 85% encode the core proteome com-
mon to all kinetoplastids. Many of these function in metab-
olism and can be described as house-keeping genes, similar
to those found in higher eukaryotes. A second category
contains genes restricted to kinetoplastids, with no ortho-
logues in higher eukaryotes. These include sequences
encoding cytoskeletal proteins, RNA editing components
and other metabolic enzymes. A third category appears
to be restricted to Leishmania: these number 1,000,
12% of the genome (El-Sayed et al., 2005a). Many of
these genus-speciﬁc genes have no conserved or recognis-
able functional domains and it is reasonable to predict that
some of them function in host/pathogen interactions.
Annotation of the L. major genome beneﬁted consider-
ably from the comparative genomics approach developed
in the Tritryp projects: based on chromosomal position
and sequence similarity, orthologues of genes experimen-
tally characterised in the trypanosomes could be identiﬁed
in Leishmania and vice versa. This approach was used to
great eﬀect in the identiﬁcation of L. major metabolic path-
ways, which are more extensive than in either T. brucei or
T. cruzi (Berriman et al., 2005). Leishmania metabolism
reﬂects parasite lifestyle in the vector and the host and is
inﬂuenced by the availability of nutrients in both locations
(reviewed in Zilberstein, 1993; Tielens and Van Hellemond,
1998). As with the other Tritryps, Leishmania lacks the bio-
synthetic pathways for essential amino acids which must
therefore be host-derived, explaining the presence of thetum Leishmania
braziliensis
Trypanosoma brucei
32.0 26.1
1,041 30
35 11*
0.3–2.8 1–5.2
60.4 46.4
8,153 9,068
161 904
1,873 1,592
258 317
48.5 50.5
60.4 50.9
n/a 127
n/a 204/71
66 65
n/a 353
n/a 5
n/a 56
1,976 1,279
e RIME/ TATEs, SLACS ingi, RIME, DIRE, SLACs, SIRE,
VIPER
ecies) and July 2005 (for T. brucei). *, only the megabase chromosome are
cluster; RIME, ribosomal mobile element; DIRE, degenerate ingi/L1Tc-
pliced Leader Associated Conserved Sequence; SIRE, short interspersed
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major (Ivens et al., 2005). Similarly, while all the Tritryps
encode the full machinery for uptake and degradation of
glucose (Berriman et al., 2005), L. major alone appears to
have the capability to hydrolyse disaccharide sugars, prob-
ably as a consequence of sandﬂy nectar feeding that pro-
vides an alternative source of energy for the promastigote
stage of the parasite (Muller and Schlein, 2004). L. major
also encodes enzymes required for haem synthesis, which
are lacking from the other Tritryps (Ivens et al., 2005).
Haem is an important Leishmania growth factor that is
required in both extracellular and intracellular stages of
the life cycle (Chang and Chang, 1985). The last three
enzymes in the biosynthetic pathway, encoded solely by
Leishmania, share a high similarity to genes in prokaryotic
pathways, like many of the apparent kinetoplastid gene
acquisitions that lead to new metabolic activities – in the
Tritryp analysis, as many as 50 genes were identiﬁed as
likely candidates for lateral gene transfer from prokaryotic
sources (Berriman et al., 2005). It should be noted, how-
ever, that synthesis of haem has not been demonstrated
biochemically in Leishmania and genes coding for enzymes
required for the rest of the pathway have yet to be
identiﬁed.
While L. major lacks the highly expanded and divergent
large subtelomeric immune evasion gene families common
to other protozoan pathogens, the sub-telomeric regions
are not totally devoid of genes, with some sequence families
found in these locations (see Fig. 1). The largest and best
studied gene family codes for a family of phosphoglycan
scb-galactosyltransferases (SCGs). These enzymes are
involved in side chain modiﬁcations of the phosphoglycan
repeats of the major promastigote glycoconjugate, LPG
(Dobson et al., 2003). There are 14 members spread across
three subfamilies (SCG, SCGR and SCGL) but seven of the
‘‘core’’ SCG genes are found exclusively at distinct subtel-
omeric sites (Dobson et al., 2006). Interestingly, SCG
expression does not appear to be restricted to a single loca-
tion that might support an antigenic variation model in
Leishmania, similar to that operating with the T. brucei
VSGs (reviewed in Barry and McCulloch, 2001). Further
analysis is required to rigorously test this ‘‘single-cell exclu-
sive-expression’’ model (Dobson et al., 2006). It is clear,
however, that these sub-telomeric locations can facilitate
gene conversion events that may ultimately support the
strain-speciﬁc diversity in LPG galactosylation known to
be critical for successful sandﬂy transmission of diﬀerent
Leishmania strains and species (reviewed in Sacks and
Kamhawi, 2001; Kamhawi, 2006).
In contrast to the sub-telomeric SCG genes, the tan-
demly arrayed gene families coding for Leishmania surface
proteins are found at internal chromosome sites. A good
example is the GP63 gene family which encodes glycopro-
teins critical for host invasion and virulence (Joshi et al.,
2002; Yao et al., 2003). These zinc metalloproteases are
not conﬁned to Leishmania species however: a single tan-
dem GP63 gene array is present in all three Tritryp species(El-Sayed et al., 2005a), while recent studies suggest that
GP63-type proteins are conserved and functional in insect
and plant trypanosomatid species (Masini Masini d’Avi-
la-Levy et al., 2006) as well as the more distant Tricho-
monas vaginalis (Carlton et al., 2007).
In Leishmania, the GP63 locus is limited to four to six
copies in L. major and L. infantum but expanded approxi-
mately eightfold in the L. braziliensis genome (Peacock
et al., 2007). Studies with multiple isolates of L. braziliensis
and Leishmania peruviana (both L. Viannia spp., see Table
1) have shown extensive size variation and evidence of gene
re-arrangement at this locus during long-term maintenance
in the laboratory, suggesting that the GP63 locus is suscep-
tible to dynamic change in this sub-genus (Victoir et al.,
1995). This does not seem to be the case in a more limited
study in L. major (Sadlova et al., 2006). Recent analysis of
sequence diversity within a single GP63 gene copy in multi-
ple L. donovani complex strains has conﬁrmed earlier spec-
ulation that evolution of this family is inﬂuenced by mosaic
gene conversion and provides strong genetic evidence for
GP63 as an important marker for host preference in infec-
tion (Mauricio et al., 2006).
Another family of leucine-rich membrane surface pro-
teins, the PSA-2 or GP46 family, is restricted to Leishmania
spp.; analysis at both the DNA and protein levels failed to
detect GP46 in the L. braziliensis complex (McMahon-
Pratt et al., 1992). Conﬁrming this earlier study, only one
PSA-2-like gene has been annotated in the L. braziliensis
genome. This is in contrast to the genome strains of
L. major (with 25 PSA-2 genes) and L. infantum (also with
a large gene complement, although the precise copy num-
ber has been diﬃcult to determine accurately). The PSA-
2s are known to bind to host cell macrophages and protect
the parasite from complement-mediated lysis during infec-
tion with L. chagasi and L. infantum (Kedzierski et al.,
2004; Lincoln et al., 2004). In L. infantum, diﬀerent strains
that cause either visceral or cutaneous disease show consid-
erable correlative variation in the size of the repeat regions
containing the PSA-2 genes (Guerbouj et al., 2001).
The amastin genes, the largest family in the Leishmania
genome, encode small surface-expressed glycoproteins of as
yet unknown function that are conserved in T. cruzi.
Importantly, a majority of these genes are expressed specif-
ically in intracellular amastigotes in L. major and therefore
presumably contribute to survival in the host (Rochette
et al., 2005). Unlike most other large Leishmania gene fam-
ilies, the amastin genes are not present in a single array but
found on seven diﬀerent chromosomes in the L. major gen-
ome (Ivens et al., 2005). Most of these sites contain small
groups of genes (one to four copies) but two large arrays
are also present, with the largest containing amastin genes
alternating with the highly conserved tuzin genes; a similar
arrangement is found in T. cruzi but is absent from T. bru-
cei (El-Sayed et al., 2005b). The second large gene array,
not present in T. cruzi, contains amastin genes separated
by degenerate tuzin genes. A likely explanation for this
gene complexity is that a common kinetoplastid ancestor
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duplication, re-arrangement and diversiﬁcation after sepa-
ration of the Leishmania and Trypanosoma lineages. With
the exception of a lone copy on L. major chromosome
36, L. infantum and L. braziliensis have amastin gene arrays
at the same locations, although sequence read depth sug-
gests that the large amastin array with intact tuzin genes
is shorter in L. braziliensis.
Other Leishmania-speciﬁc proteins that are not necessar-
ily surface-exposed may also be important regulators of
host–parasite interactions. One interesting example is an
apparent homologue of the human cytokine macrophage
inhibitory factor (MIF). The ﬁrst cytokine to be identiﬁed,
MIF is also one of the most pleiotropic, implicated in a
wide range of cellular activities that could inﬂuence para-
site survival (Calandra and Roger, 2003). Addition of puri-
ﬁed recombinant human MIF to L. major-infected
macrophages activates parasite killing by inducible nitric
oxide synthase and TNF-a (Juttner et al., 1998). In
malaria, variations in the expression of MIF have been
associated with susceptibility to high density parasitemia,
while reduced MIF production may lead to increased
severity of disease (Awandare et al., 2006). MIF-deﬁcient
mice also show increased susceptibility to L. major (Satos-
kar et al., 2001), highlighting the important role of this
cytokine in mounting an eﬀective immune response to
infection.
MIF sequences are not conﬁned to the host, however.
All three Leishmania spp. sequenced to date have two sim-
ilar MIF gene copies located at a strand switch region (see
http://www.genedb.org/). Functional analysis of these
sequences may be of considerable interest, given that
MIF expression in the ﬁlarial worm Brugia malayi inﬂu-
ences the progression of the CD4+ T cell response to infec-
tion towards a TH2 pathway (Falcone et al., 2001). The
Leishmania MIF genes show greatest similarity to bacterial
orthologues, suggesting that they too may have been
acquired by lateral gene transfer following diversiﬁcation
from the trypanosome lineage.
5. Comparison of the L. major, L. infantum and L.
braziliensis genomes
From an evolutionary perspective, phylogenetic analy-
ses have suggested a neotropical origin for the Leishmania
genus (Stevens et al., 2001) and, while there has been some
controversy in this designation (see Kerr, 2000), this has
been largely resolved in a recent multifactorial genetic
study (Lukes et al., 2007). Irrespective of this debate, L.
braziliensis is the most genetically and biologically diver-
gent of the three sequenced species. Divergence between
the Leishmania species complexes is estimated to have
occurred 15–50 million years ago (Lukes et al., 2007),
within the same range as two potential host species, mouse
and human. Given this period of isolation, it was expected
that there would be signiﬁcant diﬀerences in both genome
architecture and gene repertoire between L. braziliensis,L. infantum and L. major. Indeed, while the genomes have
a similar DNA content of around 33 Mb, karyotypic diﬀer-
ences had already been identiﬁed by linkage group analysis
(Britto et al., 1998): L. major and L. infantum, in common
with other Old World species, have a haploid content of 36
chromosomes, while the New World species have either 35
(L. braziliensis complex) or 34 (L. mexicana complex).
These diﬀerences were shown to be due to fusion of pairs
of chromosomes (chromosomes 20 + 34 in L. braziliensis;
chromosomes 8 + 29 and 20 + 36 in L. mexicana), with
the former observation now conﬁrmed in the sequencing
project.
Surprisingly, comparison of the respective orthologous
chromosomes has revealed remarkable conservation of
both gene content and gene order in all three genome spe-
cies. Despite the diﬀerences in gene copy number within
some of the major protein-coding families described above,
not a single chromosomal re-arrangement has been identi-
ﬁed between L. major and L. infantum across the whole
genome, while L. braziliensis has only a few possible
sequence re-arrangements (Peacock et al., 2007). Equally
surprising, from the total content of 8,300 genes in each
species, only 200 can be identiﬁed as diﬀerentially distrib-
uted between the three genomes. The most divergent, L.
braziliensis, possesses 47 genes that are absent from the
other two species. In comparison, L. infantum has 27 spe-
cies-speciﬁc genes while L. major has only ﬁve (see
Fig. 2). A number of the other diﬀerentially distributed
genes are found in two out of the three species. Some of
these species-speciﬁc sequences have already been analysed
at the molecular level. Examples include the L. infantum A2
gene that encodes an amastigote-speciﬁc repeat-containing
protein previously characterised in L. donovani, the only
Leishmania sequence to date that confers a change in viru-
lence phenotype when introduced into L. major by genetic
transfection (Zhang et al., 2003); and the HASP and
SHERP genes, expressed from a single locus (absent in
L. braziliensis) in infective stages of L. major and L. infan-
tum, with their protein products localizing to the plasma
membrane and intracellular membranes, respectively, in
these species (Denny et al., 2000; Knuepfer et al., 2001).
In the Tritryp genome analyses, most genes speciﬁc to
each of the representative species were found either at the
ends of the DGCs or in the subtelomeric regions of the
chromosomes, regions that appear to be more tolerant to
genome re-arrangement. However, comparison of the three
Leishmania genomes has revealed that gene variation is not
predominantly restricted to the subtelomeric regions or
even the SSRs but is evenly distributed across the genome
(Peacock et al., 2007).
Leishmania is also distinctive from other eukaryotes in
the apparent mechanism by which species-speciﬁc gene
variation occurs. Whereas insertions/deletions and
sequence re-arrangements play major roles in gene diver-
siﬁcation in most other eukaryotes characterised to date,
degeneration of existing genes (leading to probable loss
of function) accounts for 80% of the species diﬀerences
Fig. 2. Leishmania species-speciﬁc genes. The Venn diagram shows how many of the 8,187 protein-coding genes are species-speciﬁc or shared between two
of the three sequenced Leishmania species. These genes are subdivided into those that have a predicted function (mostly through sequence identity) and
those that are of unknown function at the time of publication (the ‘‘hypotheticals’’).
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stop codons and frame shifts, generating truncated open
reading frames that are presumably not translated. One
example is the gene encoding cysteine peptidase Pfp1,
which is present as an intact gene and translated in
L. major (Eschenlauer et al., 2006). However, there are
ﬁve in-frame stop codons and a frame shift in the
L. infantum orthologue, while the syntenic region in
L. braziliensis is even more degenerate.
Pfp1 like some of the other species-speciﬁc genes,
appears to be another candidate for lateral gene transfer
from bacteria. Of the remaining species-speciﬁc sequences
not caused by loss of function, many also fall into this cat-
egory. One example is the cyclopropane fatty acyl synthase
(CFAS) gene, present in L. infantum and L. braziliensis but
absent from L. major. Acquisition of novel genes in this
way may be a mechanism for environmental adaptation
to promote survival; similar adaptations to stress or other
stimuli may lead to the redundancy of other sequences
clearly identiﬁed as pseudogenes in the Leishmania gen-
omes (Peacock et al., 2007). In the case of CFAS, acquisi-
tion of this gene may have an impact on parasite survival in
the host, since the CFAS orthologue in Mycobacterium
tuberculosis is associated with increased virulence and per-
sistence, functions that apparently require cyclopropana-
tion of a mycolic acid substrate in the bacterial cell wall
(Rao et al., 2005).
Despite its chromosomal plasticity (Martinez-Calvillo
et al., 2005), the incredible conservation of synteny
revealed by comparative genomic analyses of these three
species suggests that the Leishmania genome is highly sta-
ble and has not undergone major genomic re-arrangements
during speciation. One contributing factor to this stability
could be a lack of mobile DNA elements, as originally
demonstrated in the L. major genome and veriﬁed in
L. infantum. The comparative sequencing project has
revealed some surprising observations, however, one of
the most striking being the presence of transposable
elements in L. braziliensis.6. Retrotransposons in L. braziliensis
Repeat sequences are a common feature of both pro-
karyotic and eukaryotic genomes, with diﬀerent categories
contributing 50% or more to some eukaryotic genomes.
Among these groups are the mobile genetic elements which,
by virtue of their ability to move to diﬀerent chromosomal
locations, are considered important in shaping the course
of genome evolution. Mobile elements are widespread in
the biological kingdom. When actively proliferating (Wick-
stead et al., 2003), they can create and destroy or modify
existing genes and regulatory elements, thus reshaping the
structure and function of their host genomes. When no
longer able to proliferate (‘‘dead repeats’’), they are still
important markers for evolutionary events, a palaeonto-
logical record.
Although some protozoan parasites carry no mobile
elements or any vestige of them (Katinka et al., 2001;
Carlton et al., 2002; Gardner et al., 2002; Xu et al.,
2004), diﬀerent types of transposable elements have been
found in kinetoplastids. The genomes of T. brucei and
T.cruzi contain both highly reiterated interspersed ele-
ments (Bhattacharya et al., 2002; Wickstead et al.,
2003; El-Sayed et al., 2005b) and retroelements, transpo-
sons that require reverse transcription from an RNA
intermediate. Depending on their mechanism of transpo-
sition, these retroelements are classiﬁed either as long ter-
minal repeat (LTR) retroelements (or retrotransposons)
or non-LTR retroelements (the retroposons), which
include the short and long interspersed nuclear elements
(Singer, 1982).
In some kinetoplastids, retrotransposons (VIPER), site-
speciﬁc retroposons (SLACS, CZAR, CRE) and non-site-
speciﬁc retroposons (Ingi and L1Tc) have been described
(Kimmel et al., 1987; Murphy et al., 1987; Martin et al.,
1995; Teng et al., 1995; Wickstead et al., 2003). Trypano-
soma cruzi bears the highest number of repetitive
sequences, which occupy at least 50% of the parasite
genome. Long terminal repeat (LTR) and non-LTR
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cruzi and T. brucei genomes, respectively (El-Sayed et al.,
2005b). These mobile elements probably played an impor-
tant role in shaping these parasites’ genome organization
and evolution.
In contrast, analysis of several Leishmania species orig-
inally indicated a lack of active retroelements (Bhattach-
arya et al., 2002). In the L. major and L. infantum
genomes, it was possible to detect remnants of retroposons,
named DIREs (degenerate ingi/L1Tc-related elements),
which had been previously described in trypanosomes
(Ghedin et al., 2004; Bringaud et al., 2006). Other relics
of retroelements, distinct from ingi/L1Tc, were also
detected in L. major. These are conserved in some Old
and New World Leishmania species, but absent from the
T. cruzi and T. brucei genomes (Pedrosa et al., 2006).
Against this background, in addition to these degenerate
retroelements, it was surprising to detect potentially active
retroposons in the genome of L. braziliensis (Peacock et al.,
2007). Similar to the organization described for the SLACS
and CZAR elements in T. brucei and T. cruzi, these non-
LTR retrotransposons are associated with the spliced lea-
der array in L. braziliensis (Aksoy et al., 1987; Villanueva
et al., 1991).
In addition, the organization of the L. braziliensis
telomeres is remarkably distinct from the Old World spe-
cies. They accommodate the so called TATEs (Telomeric
Associated Transposable Elements), a family of 20–30
novel DNA transposable elements, each including puta-
tive reverse transcriptase, phage integrase (site-speciﬁc
recombinase) and DNA/RNA polymerase domains.
These are highly conserved retroelements with a precise
site of insertion within the telomeric hexamer repeats
and a typical TT duplication ﬂanking the transposon.
The clusters of tandemly arrayed TATEs at the ends of
chromosomes resemble ribosomal mobile element
(RIME)/Ingi retroelements that are also organised in
clusters within the subtelomeric regions of T. brucei chro-
mosomes (Bringaud et al., 2002; Peacock et al., 2007).
Based on current annotation of the L. braziliensis gen-
ome, TATEs are present on at least 12 chromosomes,
precisely inserted in the middle of the GGGTTA repeats
(Peacock et al., 2007). The TATE-containing L. brazilien-
sis chromosome ends share longer stretches of sequence
with a higher number of heterologous chromosomes,
compared with the corresponding chromosomes in L.
major (Brito, L.O. et al., unpublished data). On the other
hand, only remnants of TATE elements are detected at
L. braziliensis internal chromosomal sites. Besides the
bias of abundance of these elements at the chromosome
ends, selection against disruption of coding regions at
chromosome central domains could explain TATE distri-
bution patterns. To understand the role of the TATEs in
shaping the L. braziliensis genome, it will be necessary to
improve genome assembly and further analyse TATE
distribution in diﬀerent strains and species of the Viannia
subgenus.7. RNAi in L. braziliensis
Among diﬀerent functional classes of non-coding
RNAs, there is a large class of post-transcriptional regula-
tors implicated in gene expression control in various organ-
isms. Two classes of small RNAs, the short interfering
RNAs (siRNAs) and the microRNAs (miRNAs) have been
extensively studied in gene silencing. Initially described in
Caenorhabditis elegans (Lee et al., 1993; Wightman et al.,
1993), the term RNA interference (RNAi) was used to
describe these events (Fire et al., 1998) and link them to
similar post-transcriptional silencing phenomena in plants
and fungi (Jorgensen, 1990; Romano and Macino, 1992).
Currently, RNAi is the best-known mechanism of gene
silencing, an evolutionary conserved process in which dou-
ble-stranded RNA induces the sequence-speciﬁc degrada-
tion of homologous mRNA (Fire et al., 1998). Besides its
role in the control of endogenous mRNAs, the process
seems to have an important defensive role against viruses
and mobile element activity.
An RNAi mechanism was rapidly identiﬁed in T. brucei
(Ngo et al., 1998) but has not been demonstrated in other
kinetoplastids including L. major and T. cruzi (Robinson
and Beverley, 2003; El-Sayed et al., 2005b). Therefore,
one of the most unexpected diﬀerences between the
sequenced Leishmania genomes is the identiﬁcation of
genes implicated in the RNAi pathway in L. braziliensis.
One of the hallmarks of this pathway is Dicer activity,
which converts double-stranded RNA (dsRNA) into small
interfering RNA (siRNA). Annotation of the genomes of
three Leishmania species and the trypanosomes did not
reveal a Dicer orthologue (Berriman et al., 2005; El-Sayed
et al., 2005b; Ivens et al., 2005; Peacock et al., 2007).
Instead, it was speculated that a combination of indepen-
dent proteins carrying the relevant domains DSRBD,
DEAD/H box RNA helicase and RNase III could be
responsible for Dicer activity in T. brucei. Orthologues of
genes carrying these domains have also been annotated in
the L. braziliensis genome (see Fig. 3 for an outline of the
putative RNAi machinery in L. braziliensis, compared with
T. brucei).
Curiously, it has recently been shown that a T. brucei
Dicer-like protein (TbDcl1), quite divergent from the typi-
cal Dicer proteins described for other eukaryotes, is
required for the generation of siRNA-size molecules and
for RNAi (Shi et al., 2006a). Interestingly, a TbDcl1 gene
is also present in L. braziliensis (Peacock et al., 2007),
although there are no orthologues in T. cruzi, L. major or
L. infantum.
Another crucial component of the RNAi pathway is
Argonaute, an endonuclease involved in the dsRNA-trig-
gered cleavage of mRNA. Unlike L. major and L. infantum,
L. braziliensis contains one orthologue for Ago1, the func-
tional argonaute gene of T. brucei. TbAGO1 can be func-
tionally replaced by the human gene Argonaute 2, which
suggests that TbAGO1 has the endonuclease activity
involved in mRNA target degradation in the trypanosome
Fig. 3. RNAi machinery: Leishmania braziliensis versus Trypanosoma brucei. Schematic representation of the main components of the RNAi pathways
identiﬁed by sequence similarity and/or functional evaluation in T. brucei (Tb) and L. braziliensis (Lb). Comparisons of the gene products and their
domains in each species are accompanied by their GeneDB gene IDs; Tb927, T. brucei genes; LbrM, L. braziliensis genes. Domain IDs are depicted on the
left. RGG indicates a domain containing arginine-glycine-glycine repeats; SNase indicates the Staphylococcal nuclease domain present in TudorSN
proteins. *Indicates genes conﬁrmed to be functionally active in the T. brucei RNAi pathway.
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contains the typical argonaute domains PAZ and PIWI,
the latter containing conserved amino acid residues that
are essential for functional TbAGO1 (Shi et al., 2004). In
addition, an N-terminal RGG domain, present in TbA-
GO1 and shown to be essential for its association with
polyribosomes, is also present in the L. braziliensis Ago1
gene (Shi et al., 2004). Thus, the L. braziliensis gene prod-
uct may also participate in the control of translation.
It is an intriguing observation that RNAi machinery is
present in only one of the three, highly syntenic Leishmania
species sequenced to date. While this could indicate a lack
of biological relevance for this pathway in the parasite, a
more interesting possibility is that the availability of RNAi
in L. braziliensis plays a role in the biological diﬀerences
observed between the two subgenera. The demonstration
of RNAi and its biological consequences in L. braziliensis
awaits further experimentation.
Whether RNAi machinery has been lost or acquired
across the kinetoplastid species and genera is an open ques-
tion. Examination of the syntenic regions in L. major and
L. infantum identiﬁed remnants of Argonaute in both, an
observation that favours the proposal that RNAi was lost
in the subgenus Leishmania. This speculation is reinforced
by the conservation of key RNAi members between organ-
isms as distant as T. brucei and humans (Shi et al.,2006a,b). It is relevant to stress that RNA viruses have
been detected in species of the subgenus L. Viannia (Guil-
bride et al., 1992; Widmer and Dooley, 1995), suggesting
that L. braziliensis could have retained RNAi as an antivi-
ral defense mechanism (although there is also a single
report of an RNAi virus in L. major; Scheﬀter et al.,
1995). In addition, RNAi could have a role in regulating
the function of the L. braziliensis-speciﬁc transposable ele-
ments described above. A role for RNAi as an endogenous
mechanism to hamper expression of speciﬁc genes and
defend cells from viruses and mobile elements has been
demonstrated in a range of organisms, including T. brucei
(Wickstead et al., 2003; Ullu et al., 2004).
The discovery of a Leishmania RNAi mechanism could
also be of practical importance, given the wide and eﬀective
use of inducible RNAi methods to study gene function in
other eukaryotes. An RNAi system for reducing gene
expression would be especially relevant in Leishmania, a
diploid pathogen that lacks a sexual cycle, and provide
an interesting alternative to the classical two-step gene
knockout strategy (Cruz et al., 1991). RNAi has been rig-
orously tested for in L. major and L. donovani with no suc-
cess (Robinson and Beverley, 2003). Detection of an RNAi
machinery so similar to that of T. brucei in L. braziliensis,
however, suggests that this mechanism may be shown to be
a useful tool in L. braziliensis. A word of caution however:
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impedes the generation of null mutants for essential genes,
may also interfere with the outcome of RNAi experiments.
In fact, downregulation of T. brucei essential genes by
RNAi led to selection of cell lines that escaped from the
deleterious eﬀect of RNA interference (Ullu et al., 2004).
Notwithstanding this concern, the combination of RNAi
and classical reverse genetic approaches promises to bring
novel insights into the functional biology of Leishmania
parasites.
8. How do the genome sequences impact on our
understanding of parasite tropism?
It is premature to speculate on how knowledge of the
genome sequences of diﬀerent Leishmania species will
impact on our global understanding of disease phenotype.
However the primary comparative analysis (Peacock et al.,
2007) supports some preliminary observations. Firstly, the
genes that diﬀer between the three species are good candi-
dates for functional analysis to determine their roles in
establishment of infection. With the A2 gene as a precedent
(Zhang et al., 2003), it can be speculated that one or more
of these sequences, expressed separately or together, may
impact upon the course of disease. Testing this hypothesis
will require the generation and functional testing of speciﬁc
mutations in suitable models of infection. Murine models
of CL are well-established, with experimental L. major
infection reproducing distinct aspects of the clinical spec-
trum of human disease (reviewed in Gumy et al., 2004).
The establishment of a dermal infection model, that intro-
duces small numbers of infective L. major metacyclics into
the host dermis via sandﬂy feeding, more closely mimics the
natural course of parasite transmission (Belkaid et al.,
1998). Murine models for L. infantum and L. braziliensis
are not as well advanced, partly because these species are
more diﬃcult to grow and diﬀerentiate in vitro and partly
because of the variable sensitivity of model mouse strains
to infection with these parasites. Progress has recently been
made, however, in the development of dermal models for
both L. infantum and L. braziliensis infection (Ahmed
et al., 2003; de Moura et al., 2005). For all species, more
work is required to relate the immune correlates of protec-
tion in mice to those that are important in human and, as
appropriate, canine infection.
Second, as most of the species-speciﬁc genes encode pro-
teins sharing little identity with other eukaryotic sequences,
the use of a combination of genetic, biochemical and
immunological analyses will be essential to help delineate
relevant biological functions. It will also be necessary to
unravel the importance of those tandemly repeated genes
that vary in copy number between species, given that this
mechanism can support increased gene expression and
potentially lead to detectable phenotypic eﬀects. In this
context, the recently published whole genome microarray
analyses suggest that RNA expression is largely constitu-
tive throughout the Leishmania life cycle with few genesshowing increased expression at the RNA level in diﬀerent
parasite stages (Holzer et al., 2006; Leifso et al., 2007). Fur-
ther studies are required to verify these observations in dif-
ferent parasite species and correlate RNA and protein
expression levels, using high resolution proteomic methods
(Foucher et al., 2006).
A third observation from the comparative genome analy-
sis is that, despite the well-conserved synteny between the
three model species, L. braziliensis may have the capacity
for more extensive genomic reorganisation, given the puta-
tive retrotransposons and RNAi machinery found in this
species. Clearly, whether RNAi actually operates as a func-
tional mechanism in L. braziliensis awaits deﬁnitive experi-
mental validation, while the functional relevance of the
retroelements requires more extensive multiple strain analy-
sis to determine possible levels of sequence variation. How-
ever, it cannot be discounted that retrotransposons play a
role in shaping the L. braziliensis genome, impacting on the
diﬀerent disease outcomes associated with this species.
9. Future perspectives
Sequencing the genomes of three Leishmania species,
with a fourth in progress, has provided a wealth of new
information that is reshaping research initiatives for leish-
maniasis. Extending this type of analysis to further species
and virulent strains may reveal further surprises. Of most
immediate practical application perhaps are the unlimited
number of potential vaccine candidates that are now avail-
able and require robust evaluation, to identify the most
favourable molecules to incorporate into clinical trials
(Kedzierski et al., 2006). Similarly, the Leishmania-speciﬁc
metabolic pathways revealed by comparative analysis are
underpinning focused biochemical analyses to identify
valid drug targets for development. New, more sensitive
and speciﬁc diagnostic reagents for the leishmaniases
should also emerge from exploring the diﬀerent genome
sequences.
More fundamentally, genomic knowledge is revealing fas-
cinating insights into Leishmania biology. In particular, the
current comparative analyses are generating testable
hypotheses relevant to understanding the importance of par-
asite genotype in pathogenesis. It is possible that just a few
species-speciﬁc parasite genes are crucial to disease outcome
and/or alternatively, that expression levels of key conserved
parasite genes diﬀer considerably both between and within
species (perhaps as a consequence of variation in gene copy
number). It is also possible that the parasite genome may
play only a minor role in determining disease phenotype.
In-depth functional analyses may ultimately unravel the rel-
ative contribution of parasite genes to disease progression in
this spectrum of crippling infections.
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